Acne & Hair Loss

Androgenic hair loss and acne are two of the most common side effects users encounter when running anabolic compounds and two of the most manageable with the right pharmaceutical approach. Both are driven primarily by androgens, both respond predictably to well established pharmaceutical interventions, and both are significantly easier to prevent than to reverse after the fact. Getting ahead of these side effects before they become problems is the approach that actually works.

True North Performance carries the complete range of pharmaceutical compounds for acne and hair loss management from DHT blocking 5-alpha reductase inhibitors to topical hair retention support to the most effective pharmaceutical acne treatment available.

Hair Loss | Understanding the Mechanism

Androgenic alopecia is the pattern hair loss associated with androgens and is driven by DHT (dihydrotestosterone) binding to androgen receptors in hair follicles, progressively shrinking them over time until they can no longer produce visible hair. Testosterone converts to DHT via the 5-alpha reductase enzyme, which means compounds that raise testosterone levels including exogenous testosterone which accelerate this process in genetically predisposed individuals. DHT derived compounds like Masteron, Winstrol, and Anavar are intrinsically androgenic at the follicle level regardless of 5-AR activity, meaning 5-AR inhibitors don’t mitigate their hair loss potential. This is worth understanding before choosing compounds if hair retention is a priority.

Finasteride Canada

Finasteride is a selective type II 5-alpha reductase inhibitor; it blocks the enzyme primarily responsible for converting testosterone to DHT in scalp tissue, reducing scalp DHT levels by approximately 60–70%. At 1mg per day it is the standard pharmaceutical intervention for androgenic hair loss and is well documented for both efficacy and tolerability in long term use. Finasteride is most effective as a preventative, started early in the hair loss process before significant follicle miniaturization has occurred, it substantially slows or halts progression for most users.

Dutasteride Canada

Dutasteride inhibits both type I and type II 5-alpha reductase isoforms compared to Finasteride’s type II inhibition only producing scalp DHT reductions of approximately 90% versus Finasteride’s 60–70%. This makes Dutasteride significantly more potent for DHT suppression and more effective for users who don’t respond adequately to Finasteride, or who are running higher androgen loads from performance compounds that produce more aggressive DHT elevation. The trade off is a longer half-life as Dutasteride takes several months to clear the system fully, which matters for users who cycle on and off 5-AR inhibition.

Minoxidil Canada

Minoxidil works through a completely separate mechanism from 5-AR inhibitors,  it is a vasodilator that increases blood flow to hair follicles, extending the anagen (growth) phase of the hair cycle and supporting follicle function independent of DHT activity. This makes it complementary to Finasteride or Dutasteride rather than a replacement and the combination of DHT suppression from a 5-AR inhibitor and follicle stimulation from Minoxidil covers both the androgenic mechanism and the follicle health dimension of hair retention simultaneously.

Minoxidil is available in topical solution and foam formats for scalp application. Oral Minoxidil at low doses has also gained significant traction for hair retention with a systemic effect profile that some users find more consistent than topical application.

Isotretinoin (Accutane) Canada

Isotretinoin is the most effective pharmaceutical acne treatment available. A retinoid compound that reduces sebaceous gland activity, sebum production, and the comedogenic environment that drives both regular and cycle related acne. It is most relevant for users experiencing significant acne that hasn’t responded to topical treatments, the severe, cystic, or widespread acne that some users develop on high androgen protocols.

Isotretinoin requires careful dosing and monitoring as it is hepatotoxic at standard doses and blood work monitoring liver enzymes is standard practice during a course. It also has significant teratogenicity, which is the primary reason it is tightly controlled in regulated medical contexts. A typical course runs 16–24 weeks at weight adjusted doses, producing significant and often permanent reduction in acne severity for most users who complete it.

Cycle Related Acne Management

Anabolic steroid related acne differs from standard hormonal acne in its severity and distribution as back acne (bacne), chest acne, and shoulder acne are particularly common with high androgen protocols. Topical treatments are rarely sufficient for cycle related acne of any significance. The pharmaceutical approach combines sebum control which Isotretinoin addresses most effectively with androgen management where possible. Keeping DHT in check with a 5-AR inhibitor during testosterone heavy cycles reduces the androgenic stimulus driving sebaceous gland overactivity alongside the primary acne treatment.